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Natural phage nanoparticle-mediated real-time
immuno-PCR for ultrasensitive detection of
protein marker†
Heng Zhang,zya Ye Xu,ya Qiuying Huang,a Changqing Yi,b Tan Xiaob and
Qingge Li*a
Current immuno-PCR methods either use bare or nanostructured
DNA as a reporter or combine phage display for antigen binding
and reporting, however, they are often complex to carry out and
lack universality. We present a novel and universal design of
immuno-PCR termed natural phage nanoparticle-mediated real-
time immuno-PCR.
Many disease markers at low levels in body fluids are parti-
cularly significant for clinical cases. However, methods for
protein detection are not as sensitive as those for specific
DNA detection because the latter can be amplified exponen-
tially by polymerase chain reaction (PCR). Sano et al.1 intro-
duced PCR into immunoassays by using a reporter DNA that is
amplified to a diagnostic concentration by PCR after immune
reaction and established the immuno-PCR method to detect
proteins of low abundance. In the initial immuno-PCR method,
a protein A-streptavidin chimera bound to a biotinylated linear
plasmid1 was used to bridge the detection antibody and the
reporting DNA. Later, nanostructured networks self-assembled
based on biotin–streptavidin interaction2,3 were proposed and
are now widely used for qualitative testing in both fundamental
and applied immunological research.4–8 However, the difficult
and complex preparation of chimera and the nanostructured
networks has hindered immuno-PCR from wide acceptance.
Alternative reporting systems were also reported. For example,
liposomes embedded with DNA reporters in the bilayer were
proposed to be universal reporting systems for immuno-PCR.9
Another strategy takes advantage of the phage display technique
to introduce single chain variable fragments (scFv) for antigen
binding while inherent phage DNA was used as a reporter
template for PCR.10 However, scFv molecules normally have
an apparent affinity that is typically 10- to 1000-fold lower than
their parent monoclonal antibody.11 Furthermore, acquisition
of such phages with scFv avidity involves a complex and time-
consuming procedure that needs repeated screening by bio-
panning. More recently, Hee-Joo Kim et al.12 exploited phagemid
DNA contained in M13 bacteriophage displaying peptides that
bind to an analyte–antibody immune complex to develop non-
competitive immuno-PCR for small molecules. This method,
however, like the phage display strategy, requires a specific scFv
display and cannot be applied to different analytes.
To construct an ease-of-use and universal reporting system
for immuno-PCR, we hereby introduce the use of natural phage
nanoparticles (T7 phage) for immuno-PCR assay. We tested this
idea by using the human hepatitis B surface antigen (HBsAg) as
a model analyte. HBsAg is a viral protein marker for hepatitis B
virus (HBV) infection and its highly sensitive detection allow
early diagnosis of HBV infection and confirmation of virus
clearance. Currently, the most widely used enzyme-linked
immunosorbent assay (ELISA) for HBsAg has a limit of detec-
tion (LOD) of ca. 0.2 ng ml1, which is often not low enough to
meet the clinical requirements.
Details of preparation and characterization of the T7-antibody
complex, optimization of immuno-PCR conditions, and real-
time sandwich immuno-PCR for human HBsAg are provided in
the data supplement that accompanies the online version of
this article (see Materials and methods, ESI†). The assay
procedure is illustrated in Fig. 1. A monoclonal capture anti-
body against HBsAg was coated onto the inner surface of the
PCR tubes, which were previously coupled with glutaraldehyde.
The target antigen in the sample was captured by the immobi-
lized capture antibody. Then, the T7 phage–antibody complex
bound with the antigen through the monoclonal detection
antibody in the complex, thereby forming the immune complex
containing the T7 phage. Because T7 could be easily lysed
by heating, it could directly serve as the template for PCR,
which was initiated by a denaturation step at 95 1C for 6 min.
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The real-time PCR based on displacing probes13 was then
performed to quantify the DNA template of T7, which in turn
would reflect the amount of antigen to be detected.
Preparation of the T7–antibody complex relies on the
assumption that T7, as a natural phage nanoparticle, should
have a sufficient number of free amino groups on the surface.
We tested this assumption by chemical staining of T7 using
fluorescein isothiocyanate (FITC), which could react with an
amino group and make it fluorescent. As expected, T7 phages
became strongly fluorescent after being stained with FITC (see
Fig. S1, ESI†). The number of amino groups on the surface of T7
phages were determined to be (1.492  0.201)  103 per phage
by the 2,4,6-trinitrobenzenesulfonic acid (TNBS) method.14 The
T7 phage was conjugated to the detection antibody by coupling
its amino groups with a thiolated antibody using a crosslinker,
sulfosuccinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate
(sulfo-SMCC), via an ester reaction. The T7 phage–antibody
complex was characterized using a JEOL JEM-2100 (100 kV)
transmission electron microscope. As shown in Fig. 2, the
surface of free T7 phages was sleek whereas the surface of the
T7 phage–antibody complex was obviously blurred, confirming
that the antibodies were present on the T7 phage surface.
Regular ELISA plates cannot be directly used in a PCR
machine because of their flat bottoms and different sizes from
those of the PCR blocks, therefore hindering immuno-PCR
from being conducted with simple handling and ordinary
apparatus.15 To address this problem, we modified the inner
surface of regular polypropylene PCR tubes by immobilizing
glutaraldehyde, which could attach the captured antibody
through chemical linking and allow both immune reaction
and PCR to be performed in a single module. Another problem
with the immuno-PCR approach is the nonspecific binding,
which can cloud positive results with high background signals.
Sufficient blocking, washing and pre-PCR sample preparation
are preferable ways to overcome this problem. After extensive
optimization, we concluded that satisfactory results could be
obtained by including Tween-20 in the blocking buffer and
sodium dodecyl sulfate (SDS) in the washing buffer (see Fig. S2,
ESI†). Upon combining immune reaction and PCR in a single
reaction tube, immuno-PCR became simple and straight-
forward and the whole procedure, starting from antigen
capture, could be finished within 4 hours for a batch of
10 samples. The manipulations also became simple as the
multiple washing steps could be carried out using an automatic
washing machine and the PCR step only involved a single step
of reagent addition.
We then evaluated the analytical performance of T7 phage-
mediated real-time immuno-PCR. We first prepared a series of
standard HBsAg solutions with concentrations ranging from
1000 ng ml1 to 0.01 ng ml1 and detected each of them in
triplicate. The typical real-time PCR profile could be obtained
for each concentration. After the cut-off fluorescence intensity
value was set in the exponential amplification region auto-
matically using the machine, the threshold cycle numbers (Ct)
could be obtained for each concentration (Fig. 3). By plotting
these averaged Ct values against the logarithmic value of each
concentration, a linear calibration curve (y = 30.72  2.79x,
y = Ct value, x = log[HBsAg] in ng ml
1, R = 0.988) was obtained
in the whole concentration range with the coefficient of varia-
tion (CV) being between 6.2% and 15.1%. To determine the
LOD of this immuno-PCR, another series of solutions of 0, 0.1,
1, 10, 100, 1000 pg ml1 of HBsAg were prepared and repeatedly
detected 10 times. By setting Ct 3SD from the blank (0 ng ml1)
as the cut-off value, we observed that the lowest concentration
that could always be distinctively detected as positive was
0.1 pg ml1, which was therefore set as the LOD of this assay
(Fig. S3, ESI†). Such a LOD value was approximately 2000-fold
lower compared with that obtained from a regular ELISA for
HBsAg. These results evidenced that real-time immuno-PCR
using a natural T7 phage is a highly sensitive method.
We then evaluated this method by detecting HBsAg in
human serum samples. The 74 serum samples were collected
Fig. 1 Schematic diagram of immuno-PCR using the T7 phage–antibody
complex for detection of human HbsAg.
Fig. 2 TEM images of uranyl acetate negatively stained T7 bacteriophage
(A) and T7–antibody complex. (B) The insets show higher resolution images of
the same sample.
Fig. 3 Quantitative detection of standard human HBsAg solutions by phage-
mediated immuno-PCR. (A) Real-time PCR amplification curves. Curves a–f repre-
sent serial 10-fold dilutions of HBsAg from 1000 ng ml1 to 0.01 ng ml1. Curve g
stands for the negative control that had no HBsAg antigen added, and the
fluorescent signal was observed because of non-specific absorption. (B) Calibration
plot of log HBsAg concentration versus threshold cycles (Cts). The results obtained
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from both HBV-infected and non-HBV-infected persons. All of
the samples were previously analysed by ELISA for HBsAg
and real-time PCR for the HBV DNA. All the samples were
renumbered and the detection result for each sample was
blinded to the person who conducted real-time immuno-PCR.
Our detection results showed that of the 74 samples, 29 were
HBsAg positive and 45 were HBsAg negative. By referring to the
results of ELISA and real-time PCR, a second person found that
our result for each sample was completely concordant with the
ELISA result and the HBV DNA status detected by real-time PCR
was also in line with the two immunoassays. These results
supported the feasibility of using this immuno-PCR method in
clinical settings.
Recent advances in the field of clinical diagnostics have
been incorporated successfully for detection of numerous
infectious agents including human and animal viruses with
significant improvement in sensitivity and specificity.7 Owing
to the low level of transcription of the viral gene as one of the
persistence mechanisms of the virus in its host, resulting in
difficulties in detection, HBsAg is still a challenging target for
immuno-PCR.5,16 The hereby described immuno-PCR method
based on the natural phage offers several advantages over
the current immuno-PCR methods. First, the natural phage
nanoparticle is a universal and two-functional reagent in
immuno-PCR. The T7 phage is a widely available carrier for
molecular cloning and it can be conjugated with any type of
antibody regardless of the antigen. The large number of amino
groups on the surface makes the T7 phage a convenient carrier
for antibody labelling. Meanwhile, the template DNA is
naturally encapsulated inside the phage nanoparticles, which
offer a safe shelter for DNA against chemical or enzymatic
degradation by impurities present in the sample. Second,
phage-mediated immuno-PCR facilitated prevention of PCR
product contamination problems. Because contaminated DNA
from the environment, carryover by pipette tips or genomic
DNA contamination remaining in the samples can all be
eliminated by DNase I while the template DNA remains intact
inside the phage, false-positive results would be substantially
decreased. Third, the use of ordinary PCR tubes for both
immune reaction and PCR renders this method compatible
with all current real-time PCR machines, thereby simplifying
the operation and reducing the cost as well.
In conclusion, we have described a novel version of
immuno-PCR based on the natural phage nanoparticles for
the first time. The protocol for using a prepared T7 phage–
antibody complex as a detection reagent for immuno-PCR was
straightforward and practical as shown in the detection of
HBsAg. Additional merits such as compatibility with real-time
PCR machines, easy preparation and purification of detection
reagents, simple protocol, low cost, high sensitivity, and low
false positive rate, etc., were also revealed by our preliminary
experimental data. Improved sensitivity and lower nonspecific
binding could be achieved through further optimization of
experimental conditions. As the technique matures through
continued research, this new model will likely be a potential
toolkit for immuno-PCR in the detection of a variety of protein
biomarkers.
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